Mesoblast (MESO) Times Interest Earned (2015 - 2023)
Mesoblast's (MESO) quarterly Times Interest Earned came in at $277.74 in Q2 2023, up 21.15% year-on-year from $229.25 in Q2 2022, and up 16.36% quarter-over-quarter from $238.69 in Q1 2023.
Mesoblast (MESO) Times Interest Earned (2015 - 2023) Analysis & Trends
Mesoblast has disclosed Times Interest Earned across 8 years of filings, most recently posting $277.74 for Q2 2023.
- Times Interest Earned for Q2 2023 came in at $277.74, up 21.15% year-over-year; the trailing twelve-month figure through Jun 2023 was $57.04 (up 99.52% YoY), and the FY2025 annual result was -$2.7, up 3.92% from the prior year.
- Times Interest Earned came in at $277.74 for Q2 2023 at Mesoblast, up from $238.69 in the prior quarter.
- In the past five years, Times Interest Earned ranged from a high of $588.38 in Q2 2021 to a low of -$3519.9 in Q1 2020.
- The 5-year median for Times Interest Earned is $142.73 (2022), against an average of -$82.75.
- Peak annual rise in Times Interest Earned reached 15239.21% in 2020, while the deepest fall reached 1620.85% in 2020.
- Mesoblast's Times Interest Earned stood at -$169.2 in 2019, then jumped by 94.42% to -$9.44 in 2020, then surged by 2649.97% to $240.81 in 2021, then slumped by 132.26% to -$77.68 in 2022, then surged by 457.54% to $277.74 in 2023.
- The last three Times Interest Earned figures came in at $277.74 (Q2 2023), $238.69 (Q1 2023), and -$77.68 (Q4 2022), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 3.58 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 11.50 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -258.33 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 547.67 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 11.79 |
| 10 | Mesoblast | 21.68 Bn | 21.55 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 277.74 |
| Mar 31, 2023 | 238.69 |
| Dec 31, 2022 | -77.68 |
| Sep 30, 2022 | 63.45 |
| Jun 30, 2022 | 229.25 |
| Mar 31, 2022 | 222.01 |
| Dec 31, 2021 | 240.81 |
| Sep 30, 2021 | 246.51 |
| Jun 30, 2021 | 588.38 |
| Mar 31, 2021 | -201.33 |
| Dec 31, 2020 | -9.44 |
| Sep 30, 2020 | -2.98 |
| Jun 30, 2020 | 322.26 |
| Mar 31, 2020 | -3,519.93 |
| Dec 31, 2019 | -169.20 |
| Sep 30, 2019 | -171.54 |
| Jun 30, 2019 | 2.10 |
| Mar 31, 2019 | 231.44 |
| Dec 31, 2018 | -213.43 |
| Sep 30, 2018 | 222.94 |